C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: 12 week pilot intervention study..
- Who it may be relevant to
- Registry conditions: Cancer Survivors. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Does High-Intensity Functional Training Improve Patient Movement and Quality of Life? A Study of CrossFit® in Cancer Survivors
Overview
This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer survivors.
Detailed description
A 12-week pilot intervention study introducing a high-intensity functional training program to 100 cancer survivors and evaluate the effects of this program on patient quality of life, functional capacity, and body composition. Response rates will be determined using various recruitment methods and estimate differences in response rates by patient characteristics including race, gender and age. Barriers to participation in the program in contacted patients who do not enroll as well as patients who enroll and do not complete the program will be described, as will participant satisfaction with enrolled participants who complete the program. The goal of this pilot study is to help refine the recruitment and program methods for a larger intervention study to test the superiority of a high-intensity interval functional training program compared with current American Cancer Society guidelines in improving functional capacity, body composition and patient reported quality of life.
Surveys will be completed by each participant weekly and physical assessments will be completed monthly.
Interventions
- Behavioral 12 week pilot intervention study.
Participants will begin a 12-week high-intensity functional training program conducted at CrossFit® in the D, located in downtown Detroit, Northville Athletix in Northville and Five Lakes CrossFit® in Farmington Hills.
Primary outcome measures
- Enrollment rates [Time frame: Baseline]
- Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program [Time frame: Baseline to 12 weeks]
- Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program [Time frame: Baseline to 12 weeks]
- Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program [Time frame: Baseline to 12 weeks]
- Change in self-reported health-related quality of life (HRQOL) and variability using the FACT questionnaire [Time frame: Baseline to 12 weeks]
- Change in Body Composition [Time frame: Baseline to 12 weeks]
- Change in Body Composition [Time frame: Baseline to 12 weeks]
- Change in Body Composition [Time frame: Baseline to 12 weeks]
- Change in Body Composition [Time frame: Baseline to 12 weeks]
- Change in Body Composition [Time frame: Baseline to 12 weeks]
Eligibility criteria
Inclusion criteria
- Aged 18 years or older at time of program recruitment
- Diagnosed with any cancer
- Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist).
- Available transportation to and from the facility on session days
Exclusion criteria
- Widely metastatic cancers to the brain or bone may be excluded.
- Patients using mobility assistance devices may be excluded. Exclusionary criteria will be reviewed on a case-by-case basis and patients with these limitations may be included with approval from Dr. Beebe-Dimmer and the referring physician.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Barbara Ann Karmanos Cancer Institute — Detroit
Identifiers
NCT: NCT03750981 · 2018-091